Sign in with Google
|
USD 117.44
Price
-5.44
(-4.42%)
Day Change
|
|
|---|
NBIX, the overall quality is very good (Quality = 85) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
| Quality Factors |
|
55% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 8 |
| Magic Formula Rank by ROA |
1428
|
| Magic Formula Rank by ROE |
1428
|
| Magic Formula Rank by ROIC |
1222
|
| Price | 117.44 |
| PBV / Sector |
4.37 / 0.95
|
| Earning Per Share | 3.58 |
| PE / Sector |
32.80 / 29.75
|
| PEG or PE/Growth / Sector |
0.29 / -53.82
GREAT
|
| Average 1M Daily Value |
122.56 M
GREAT
|
| Average 1W Daily Value |
126.22 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
52% |
| Key Statistics |
|
75% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2024-11-16 19:31:36 |
| Symbol | NBIX |
| Name | NEUROCRINE BIOSCIENCES INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 101.25 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 12,440.77 / 10,489.82 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
AMPH 
RDY 
LNTH 
